Qualisure News

Precision Oncology Test Thyroid GuidePx® Now Available From Qualisure Diagnostics

Qualisure submits an international PCT patent application for the molecular subclassification of papillary thyroid cancer

Qualisure is awarded a $100,000 Voucher grant from Alberta Innovates

University of Calgary invests $150,000 in Qualisure through the UCeed Health Fund

Dr. Oliver Bathe (CEO) and collaborators are awarded the Jennifer Gardiner Award in Surgical Oncology Research

Qualisure announces partnership with Orlando, Florida-based Protean BioDiagnostics Inc.

Qualisure partners with Calgary, Alberta-based OncoHelix Inc.

Qualisure is awarded a $295,000 AICE-Validate grant from Alberta Innovates

Qualisure Diagnostics Inc. acquires an array of intellectual property from Innovate Calgary